Documents & Downloads

HBV Seq2 aa:179-186

CTL Epitope

HBV Seq2 aa:179-186 is a CTL epitope derived from the surface antigen of the hepatitis B virus. This peptide has been shown to effectively elicit cytotoxic T lymphocyte responses in the H-2b system following in vitro restimulation of primed T cells. It is valuable for research applications focusing on hepatitis B immunology and vaccine development.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	337464-42-3
Applications	CTL Epitope
Formula	C₅₂H₇₀N₁₀O₁₀
Molecular Weight	995.17
SMILES	CC(C)C[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.